Supernus Pharmaceuticals
SUPN
SUPN
270 hedge funds and large institutions have $1.86B invested in Supernus Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 85 increasing their positions, 92 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.09% more ownership
Funds ownership: 106.25% → 108.34% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 92
Holders
270
Holding in Top 10
1
Calls
$982K
Puts
$355K
Top Buyers
| 1 | +$16.9M | |
| 2 | +$12.6M | |
| 3 | +$9.64M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$7.37M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.88M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$5.49M | |
| 3 | -$5.23M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.65M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.36M |